The Patent Finder

IN2GEN Co., Ltd.

Also on record
Records under this name other than patents IN2GEN Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to IN2GEN Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,041,635Factor VIII polypeptide
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,407,9582-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
Formerly held
Term ended
Term ended Nov 9, 2025 · USPTO record
Term endedTerm ended Nov 9, 2025USPTO record
US 7,495,022α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors
Formerly held
Lapsed on the fee record
Ended Feb 24, 2021 · USPTO record
Lapsed on the fee recordEnded Feb 24, 2021USPTO record
US 6,962,911Pyrrolopyrimidinone derivatives, process of preparation and use
Formerly held
Term ended
Term ended Feb 15, 2021 · USPTO record
Term endedTerm ended Feb 15, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited